In the week ending November 9, 2024, 30%-40% of adults had received 2 of the most recommended vaccines, according to the latest update from the Centers for Disease Control and Prevention (CDC). An estimated 34.7% of adults reported having received a seasonal influenza vaccine, and 39.7% of adults age 75 and older have received a respiratory syncytial virus (RSV) vaccine. Likewise, 31.6% of adults aged 60–74 years at increased risk have received an RSV vaccine. …
Read MoreNew Flu Vaccine Codes—and an Update on Proposed Changes to the E/M Guidelines
Q: Do you have information on the 2017-2018 influenza vaccine codes? A: The American Medical Association (AMA) recently published a list of new and revised vaccine codes on their website (https://www.ama-assn.org/sites/default/files/media-browser/public/cpt/vaccine-long-desc-july-2017.pdf). These codes will be published in the 2018 Current Procedural Terminology (CPT) manual. The two new influenza vaccines on the list are: 90682, “Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use” 90756, …
Read MoreCDC Says Flu Vaccines Have ‘Plateaued’—so Start Promoting Its Benefits
Just the other day we shared data indicating that healthcare professionals are far less inclined to get a flu shot if their workplace doesn’t require it or offer the immunizations on site. Now comes word from the Centers for Disease Control and Prevention that the whole country’s influenza vaccination rate has plateaued—leaving us all at higher risk for an outbreak. New figures from the CDC reveal that since the 2013-2014 season, the rate for adults …
Read More